Chart Industries Evaluating Divestiture of Oxygen-Related Product Lines

Chart Industries is conducting a strategic review and evaluation of a possible divestiture of the oxygen-related product lines within its BioMedical segment. The review excludes cryobiological products that align with the company's core cryogenic expertise. There is no assurance that a transaction will be announced or completed.

“Conducting strategic review and evaluation of possible divestiture of the oxygen- related product lines within Biomedical segment”

Signals are extracted from public coverage and print archives and pinned to a verbatim quote, presented as reported by their sources; naming a company in a signal is not an accusation against it. The verified mark denotes a high-confidence, corroborated signal. See our methodology and legal notes.